| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; Liu C.-M.; Hwang T.-J.; Hsieh M.H.; CHEN-CHUNG LIU ; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. | Translational psychiatry | | 41 | |
| 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; Hwang T.-J.; Chan H.-Y.; Hsieh M.H.; CHEN-CHUNG LIU ; Liu C.-M.; Hwu H.-G.; Kuo C.-H.; Lin Y.-T.; Chien Y.-L.; Chen W.J. | BMC Psychiatry | | 1 | |
| 2020 | Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm | CHEN-CHUNG LIU ; Takeuchi H. | CNS Drugs | | 4 | |
| 2014 | Adjuvant valproate therapy for patients with suspected mixed-depressive features. | CHEN-CHUNG LIU | | 1 | 0 | |
| 2019 | Advanced Paternal Age and Early Onset of Schizophrenia in Sporadic Cases: Not Confounded by Parental Polygenic Risk for Schizophrenia | Wang S.-H.; Hsiao P.-C.; Yeh L.-L.; Liu C.-M.; CHEN-CHUNG LIU ; Hwang T.-J.; Hsieh M.H.; Chien Y.-L.; Lin Y.-T.; Huang Y.-T.; Chen C.-Y.; Chandler S.D.; Faraone S.V.; Neale B.; Glatt S.J.; Tsuang M.T.; Hwu H.-G.; Chen W.J. | Biological Psychiatry | | 7 | |
| 2015 | Altered integrity of the right arcuate fasciculus as a trait marker of schizophrenia: A sibling study using tractography-based analysis of the whole brain | Wu C.-H.; Hwang T.-J.; Chen Y.-J.; Hsu Y.-C.; Lo Y.-C.; Liu C.-M.; Hwu H.-G.; CHEN-CHUNG LIU ; Hsieh M.H.; Chien Y.L.; Chen C.-M.; Isaac Tseng W.-Y. | Human Brain Mapping | | 16 | |
| 2013 | Antipsychotic interventions in prodromal psychosis: Safety issues | CHEN-CHUNG LIU ; Liu, Chen-Chung ; Demjaha, Arsime | CNS Drugs | 17 | 18 |  |
| 2011 | ANXA7, PPP3CB, DNAJC9, and ZMYND17 genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function | Liu C.-M.; Fann C.S.-J.; Chen C.-Y.; Liu Y.-L.; Oyang Y.-J.; Yang W.-C.; Chang C.-C.; Wen C.-C.; Chen W.J.; Hwang T.-J.; Hsieh M.H.; CHEN-CHUNG LIU ; Faraone S.V.; Tsuang M.T.; Hwu H.-G. | Biological Psychiatry | | 16 | |
| 2008 | Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission | CHEN-CHUNG LIU ; HUEY-LING CHIANG | CNS Drugs | 1 | 1 | |
| 2013 | Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: An open-label study | CHEN-CHUNG LIU ; Chien Y.-L.; Hsieh M.H.; Hwang T.-J.; Hwu H.-G.; Liu C.-M. | Journal of Clinical Psychopharmacology | | 10 | |
| 2012 | Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis | HAI-GWO HWU ; Hsieh, Ming H.; Shan, Jia-Chi; CHEN-CHUNG LIU ; Huang, Wei-Lieh; Ming-Jang Chiu; Cheng, Wan-Chen; Chiu, Ming-Jang; Jaw, Fu-Shan; Hwu, Hai-Gwo ; Liu, Chen-Chung | Schizophrenia Research | 42 | 47 |  |
| 2019 | Auditory event-related potentials in antipsychotic-free subjects with ultra-high-risk state and first-episode psychosis | Hsieh M.H.; Lin Y.-T.; Chien Y.-L.; Hwang T.-J.; Hwu H.-G.; Liu C.-M.; CHEN-CHUNG LIU | Frontiers in Psychiatry | | 13 | |
| 2015 | Automatic whole brain tract-based analysis using predefined tracts in a diffusion spectrum imaging template and an accurate registration strategy | Chen Y.-J.; Lo Y.-C.; Hsu Y.-C.; Fan C.-C.; Hwang T.-J.; Liu C.-M.; Chien Y.-L.; Hsieh M.H.; CHEN-CHUNG LIU ; Hwu H.-G.; Tseng W.-Y.I. | Human Brain Mapping | | 39 | |
| 2011 | Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management | HAI-GWO HWU ; CHEN-CHUNG LIU ; CHIH-MIN LIU ; LI-REN CHANG | PLoS ONE | 11 | 12 | |
| 2010 | Bouffée Délirante: A Case of a Young Haitian Man in Taiwan | CHEN-CHUNG LIU | 臺灣精神醫學 | | | |
| 2016 | A case of tardive dystonia associated with long-acting injectable paliperidone palmitate | Ma C.-H.; Chien Y.-L.; CHEN-CHUNG LIU ; Chen I.-M.; Lin C.-H. | European Neuropsychopharmacology | | 3 | |
| 2010 | Clinical alertness to valproic acid-induced hyperammonemia-two case reports | CHEN-CHUNG LIU ; CHIH-MIN LIU | Journal of Psychopharmacology | 6 | 5 | |
| 2020 | Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase | Chien Y.-L.; Hwu H.-G.; Hwang T.-J.; Hsieh M.H.; CHEN-CHUNG LIU ; Lin-Shiau S.-Y.; Liu C.-M. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | | 10 | |
| 2010 | Creating a platform to bridge service and research for early psychosis | HAI-GWO HWU ; Liu, Chen-Chung; Hwu, Hai-Gwo; CHEN-CHUNG LIU ; Chiu, Yen-Nan; Lai, Meng-Chuan; Tseng, Huai-Hsuan | Journal of the Formosan Medical Association | 12 | 11 | |
| 2016 | Development and Psychometric Properties of the Taiwan Odd-Even Number Sequencing Test: A Nonalphabetic Measure of Working Memory. | CHEN-CHUNG LIU | | | | |
